Trial · NCT01617187
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Randomization Through Start Treatment | STARTED | Asenapine 2.5 mg BID | 98 | |
| Randomization Through Start Treatment | STARTED | Asenapine 5 mg BID | 113 | |
| Randomization Through Start Treatment | STARTED | Olanzapine 15 mg QD | 46 | |
| Randomization Through Start Treatment | STARTED | Placebo BID | 103 | |
| Randomization Through Start Treatment | COMPLETED | Asenapine 2.5 mg BID | 97 | |
| Randomization Through Start Treatment | COMPLETED | Asenapine 5 mg BID | 113 | |
| Randomization Through Start Treatment | COMPLETED | Olanzapine 15 mg QD | 46 | |
| Randomization Through Start Treatment | COMPLETED | Placebo BID | 101 | |
| Randomization Through Start Treatment | NOT COMPLETED | Asenapine 2.5 mg BID | 1 | |
| Randomization Through Start Treatment | NOT COMPLETED | Asenapine 5 mg BID | 0 | |
| Randomization Through Start Treatment | NOT COMPLETED | Olanzapine 15 mg QD | 0 | |
| Randomization Through Start Treatment | NOT COMPLETED | Placebo BID | 2 | |
| Treatment Through Study Completion | STARTED | Asenapine 2.5 mg BID | 97 | |
| Treatment Through Study Completion | STARTED | Asenapine 5 mg BID | 113 | |
| Treatment Through Study Completion | STARTED | Olanzapine 15 mg QD | 46 | |
| Treatment Through Study Completion | STARTED | Placebo BID | 101 | |
| Treatment Through Study Completion | COMPLETED | Asenapine 2.5 mg BID | 86 | |
| Treatment Through Study Completion | COMPLETED | Asenapine 5 mg BID | 102 | |
| Treatment Through Study Completion | COMPLETED | Olanzapine 15 mg QD | 41 | |
| Treatment Through Study Completion | COMPLETED | Placebo BID | 91 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01617187/flow